Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Junker

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Rheumatology|February 28, 2017
Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacityNatasja Stæhr Gudmann, Anne Sofie Siebuhr, Anne Friesgaard Christensen, et al.
Rheumatology (Oxford, England)|July 9, 2018
Surfactant protein-D, a potential mediator of inflammation in axial spondyloarthritisHeidi L Munk, Dalia Fakih, Lene Christiansen, et al.
Arthritis Research & Therapy|June 17, 2016
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritisNatasja Stæhr Gudmann, Heidi Lausten Munk, Anne Friesgaard Christensen, et al.
Clinical and Experimental Rheumatology|March 30, 2023
Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritisDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
The Journal of Rheumatology|November 17, 2017
Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical TrialJacob Sode, Sophine B Krintel, Anting Liu Carlsen, et al.
Rheumatology (Oxford, England)|June 23, 2016
A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritisMorten Aagaard Nielsen, Thomas Andersen, Anders Etzerodt, et al.
Arthritis and Rheumatism|March 30, 2007
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosusSergey V Kozyrev, Susanna Lewén, Prasad M V Linga Reddy, et al.
The Journal of Rheumatology|February 17, 2019
Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS)Ulf Sundin, Mikkel Østergaard, Daniel Glinatsi, et al.
Arthritis Care & Research|November 25, 2014
Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter studyLouise P Diederichsen, Axel C P Diederichsen, Jane A Simonsen, et al.
Cells|January 21, 2023
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial FibroblastsMorten A Nielsen, Ditte Køster, Akul Y Mehta, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Rheumatology|February 28, 2017
Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacityNatasja Stæhr Gudmann, Anne Sofie Siebuhr, Anne Friesgaard Christensen, et al.
Rheumatology (Oxford, England)|July 9, 2018
Surfactant protein-D, a potential mediator of inflammation in axial spondyloarthritisHeidi L Munk, Dalia Fakih, Lene Christiansen, et al.
Arthritis Research & Therapy|June 17, 2016
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritisNatasja Stæhr Gudmann, Heidi Lausten Munk, Anne Friesgaard Christensen, et al.
Clinical and Experimental Rheumatology|March 30, 2023
Plasma levels of multiple cardiovascular- and inflammation-related proteins analysed for associations with disease activity and anti-cyclic citrullinated peptide status in active early rheumatoid arthritisDženan Mašić, Kristian Stengaard-Pedersen, Brian Bridal Løgstrup, et al.
The Journal of Rheumatology|November 17, 2017
Plasma MicroRNA Profiles in Patients with Early Rheumatoid Arthritis Responding to Adalimumab plus Methotrexate vs Methotrexate Alone: A Placebo-controlled Clinical TrialJacob Sode, Sophine B Krintel, Anting Liu Carlsen, et al.
Rheumatology (Oxford, England)|June 23, 2016
A disintegrin and metalloprotease-17 and galectin-9 are important regulators of local 4-1BB activity and disease outcome in rheumatoid arthritisMorten Aagaard Nielsen, Thomas Andersen, Anders Etzerodt, et al.
Arthritis and Rheumatism|March 30, 2007
Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosusSergey V Kozyrev, Susanna Lewén, Prasad M V Linga Reddy, et al.
The Journal of Rheumatology|February 17, 2019
Validity and Responsiveness of Combined Inflammation and Combined Joint Damage Scores Based on the OMERACT Rheumatoid Arthritis MRI Scoring System (RAMRIS)Ulf Sundin, Mikkel Østergaard, Daniel Glinatsi, et al.
Arthritis Care & Research|November 25, 2014
Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter studyLouise P Diederichsen, Axel C P Diederichsen, Jane A Simonsen, et al.
Cells|January 21, 2023
Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naïve Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial FibroblastsMorten A Nielsen, Ditte Køster, Akul Y Mehta, et al.
Pageof 8